Ecosystem
Beta Site
Updated: Aug 23, 2022
March 2022
"February 17, 2022 08:00 AM Eastern Standard Time
SAN FRANCISCO & SHANGHAI- ShouTi Inc., a clinical-stage global biopharmaceutical company developing novel oral therapeutics to treat a wide range of chronic diseases, today introduced Basecamp Bio, a wholly owned subsidiary dedicated to fueling ShouTi’s pipeline and pursuing drug discovery partnerships."
November 2022 "Neuropeptides produce robust effects on behavior across species, and recent research has benefited from advances in...
November 2022 "Some G protein-coupled receptor (GPCR) ligands act as "biased agonists" that preferentially activate specific signaling...
November 2022 Deciphering the signaling mechanisms of β-arrestin1 and β-arrestin2 in regulation of cancer cell cycle and metastasis...
Comentários